Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis

Journal of Nephrology

Volumn 19, Issue 3, 2006, Pages 318-321

  Akar, Nejat ^a,b   Hasipek, M ^a   Ozturk, A ^a   Akar, E ^a   Tekin, M ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; AMYLOID A1 PROTEIN; AMYLOID A13 PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; MARENOSTRIN; SERUM AMYLOID A;

ALLELE; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KIDNEY AMYLOIDOSIS; MAJOR CLINICAL STUDY; MALE; TURKEY (REPUBLIC); CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; KIDNEY DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

AMYLOIDOSIS; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; KIDNEY DISEASES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM AMYLOID A PROTEIN; TURKEY;

EID: 33749041715     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 1136-43.
2. Altiok O, Séguret F, Toitou I. MEFV Sequence variants and amyloidosis: still an enigmatic question. Hum Mutat 2002; 21: 96-7.
3. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003; 48: 1149-55.
4. Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 2003; 10: 12-6.
5. Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, Kitamura Y, Kamatani N. Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis. Amyloid 2005;12: 26-32.
6. Revised nomenclature for serum amyloid A (SAA) [editorial]. Amyloid 1999; 6: 67-70.
7. Booth D, Booth S, Gillmore J, Hawkins P, Pepys M. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998; 5: 262-5.
8. Thorn CF, Lu ZY, Whitehead AS. Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells. Eur J Immunol 2003; 33: 2630-9.
9. Thorn CF, Lu ZY, Whitehead AS. Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 2004; 59: 152-8.
10. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen C, Kamatani N. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999; 105: 360-6.
11. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N. A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001; 44: 1266-72.
12. Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, Kluve-Beckerman B. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid 2003; 10: 7-11.
13. Livneh A, Langevita P, Zemer D, Zaks N, Kees S, Lidar T, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85.
14. Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis: phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003; 16: 431-4.
15. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, Akcakus M, Tastan H, Matzner Y. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 2000; 15: 118-9.
16. Akar N, Akar E, Özel D, Tekin M, Ekim M, Yalçýnkaya F. A note on mutation analysis in familial Mediterranean fever. Pediatr Nephrol 2003; 18: 196-7.
17. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, Kone- Paul I. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 163-9.